Omega-3 Fish Oil 05/25TG
Appearance Clear pale yellow liquid
Flavour Organoleptic Slight fish like
Odour Organoleptic Slight fish like
Colour Gardner < 5 (GARDNER)
Eicosapentaenoic Acid (%) 5-10%
Docosahexaenoic Acid(%) 25-30%
Total omega-3-acids (%) 35-45%
Eicosapentaenoic Acid (mg/g) 40-90mg/g
Docosahexaenoic Acid (mg/g) 210-260mg/g
Total omega-3-acids (mg/g) 300-350mg/g
Acid Value NMT 1 mg KOH/g
p-Anisidine Value NMT 20
Peroxide Value NMT 5.0 meq/kg
Moisture NMT 0.1%
Impurities NMT 0.1%
TOTOX NMT 26
Cholesterol NMT 0.5%
Unsaponifiable Matter NMT 3.0%
Saponification Value 150 to 200 mgKOH/g
Cold Test 3h @ 0oC NLT 170 gl/100g
*Lead NMT 0.1 ppm
*Arsenic NMT 0.1 ppm
*Cadmium NMT 0.1 ppm
*Mercury NMT 0.1 ppm
*DDT NMT 0.05 mg/kg
*DDD NMT 0.05 mg/kg
*DDE NMT 0.05 mg/kg
*HCB NMT 0.05 mg/kg
**PCBs NMT 0.09 mg/kg
**Dioxins NMT 2 ng/kg
Total aerobic microbial count NMT 103 CFU per g
Yeast and mould count NMT 102 CFU per g
Salmonella absent in 10 g
Escherichia coli absent in 1 g
Staphylococcus aureus absent in 1 g
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sinomega Omega-3 Refined Fish Oil EPA05/DHA25 TG is a high-purity triglyceride-based concentrate derived from deep-sea fish. It undergoes molecular distillation to enrich <strong>EPA (Eicosapentaenoic acid)</strong> and <strong>DHA (Docosahexaenoic acid)</strong>. The product features a specific fatty acid profile of 5% EPA and 25% DHA, optimized for bioavailability.</p>
<h3>Application</h3>
<ul>
<li><strong>Nutraceuticals:</strong> Formulation of softgels for cardiovascular health support.</li>
<li><strong>Functional Foods:</strong> Fortification of beverages and dairy products.</li>
<li><strong>Pharmaceuticals:</strong> Ingredient in prescription-grade lipid supplements.</li>
<li><strong>Pet Nutrition:</strong> Premium additives for canine and feline diets.</li>
</ul>
<h3>Precautions</h3>
<p>Store under nitrogen atmosphere at temperatures below -18°C to prevent oxidation. Avoid exposure to light and moisture. Consult clinical guidelines regarding anticoagulant therapy interactions before use in high-dose formulations.</p>